Hasselblatt, M., Thomas, C., Federico, A., Nemes, K., Johann, P., Bison, B., . . . Frühwald, M. (2022). SMARCB1-deficient and SMARCA4-deficient malignant brain tumors with complex copy number alterations and TP53 mutations may represent the first clinical manifestation of Li-Fraumeni syndrome. The American journal of surgical pathology, 46(9), . https://doi.org/10.1097/PAS.0000000000001905
Chicago-Zitierstil (17. Ausg.)Hasselblatt, Martin, et al. "SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors with Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome." The American Journal of Surgical Pathology 46, no. 9 (2022). https://doi.org/10.1097/PAS.0000000000001905.
MLA-Zitierstil (9. Ausg.)Hasselblatt, Martin, et al. "SMARCB1-deficient and SMARCA4-deficient Malignant Brain Tumors with Complex Copy Number Alterations and TP53 Mutations May Represent the First Clinical Manifestation of Li-Fraumeni Syndrome." The American Journal of Surgical Pathology, vol. 46, no. 9, 2022, https://doi.org/10.1097/PAS.0000000000001905.